HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection

被引:10
作者
Neukam, Karin [1 ]
Garcia-Rey, Silvia [1 ]
Cifuentes, Celia [1 ]
Macias, Juan [1 ]
Mira, Jose A. [1 ,2 ]
Vazquez, Maria J. [3 ]
Parra-Sanchez, Manuel [1 ]
Palomares, Jose C. [1 ]
Merchante, Nicolas [1 ]
Di Lello, Federico A. [1 ]
Pineda, Juan A. [1 ]
机构
[1] Hosp Univ Valme, Unit Infect Dis & Microbiol, Seville 41014, Spain
[2] Hosp Univ Valme, Dept Internal Med, Seville 41014, Spain
[3] Ctr Penitenciario Sevilla, Med Serv, Alcala De Guadaira 41500, Spain
关键词
Hepatitis C virus; HIV; RNA load; Pegylated interferon; Ribavirin; Polymerase chain reaction; HEPATITIS-C VIRUS; INTERFERON PLUS RIBAVIRIN; ANTIRETROVIRAL THERAPY; PREDICTION; COHORT;
D O I
10.1016/j.antiviral.2012.06.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of HIV coinfection on plasma hepatitis C virus (HCV) RNA load has not been reliably evaluated. We analyzed plasma HCV RNA load in 396 HCV-monoinfected and 467 HIV/HCV-coinfected patients. Median HCV RNA concentrations (interquartile range) in HCV-monoinfected patients were 5.88 (5.3-6.2) log(10) IU/mL versus 5.96 (5.6-6.5) log(10) IU/mL in HIV/HCV-coinfected individuals (p = 0.033) as determined with the Cobas Amplicor Test and 6.06 (5.4-5.7) log(10) IU/mL versus 6.3 (5.5-6.9) log(10) IU/mL (p = 0.026) using the Cobas TaqMan System. The plasma HCV RNA load in patients with HIV infection and undetectable plasmatic HIV RNA was similar to that observed in HCV-monoinfected individuals [6.02 (5.45-6.61) log(10) IU/mL versus 6.01 (5.36-6.59) log(10) IU/mL, respectively (p = 1.0)]. In conclusion, HIV coinfection tends to be associated with higher plasma HCV RNA load, however, the magnitude of the differences is small and this effect can be counterbalanced with antiviral therapy. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:212 / 215
页数:4
相关论文
共 47 条
  • [21] Detection of HCV genome in peripheral blood mononuclear cells of Iranian seropositive and HCV RNA negative in plasma of patients with beta-thalassemia major: Occult HCV infection
    Kahyesh-Esfandiary, Roya
    Sadigh, Zohreh-Azita
    Esghaei, Maryam
    Bastani, Mohammad-Navid
    Donyavi, Tahereh
    Najafi, Alireza
    Fakhim, Atousa
    Bokharaei-Salim, Farah
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (01) : 107 - 114
  • [22] Markers of Tissue Repair and Cellular Aging Are Increased in the Liver Tissue of Patients With HIV Infection Regardless of Presence of HCV Coinfection
    Naggie, Susanna
    Swiderska-Syn, Marzena
    Choi, Steve
    Lusk, Sam
    Lan, Audrey
    Ferrari, Guido
    Syn, Wing-Kin
    Guy, Cynthia D.
    Diehl, Anna Mae
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (07):
  • [23] A Multicenter Study to Clarify the Optimal HCV-RNA Negative Period during Combined Therapy with Pegylated Interferon Plus Ribavirin in Patients with Chronic Hepatitis Caused by HCV Genotype 2
    Nagoshi, Sumiko
    Koshima, Yohei
    Nakamura, Ikuo
    Funyu, Junji
    Sekine, Chuichi
    Harada, Youji
    Nishikawa, Ko
    Yoshida, Takeshi
    Matsui, Atsushi
    Sotome, Naoki
    Toshima, Kenichi
    Takegoshi, So
    Shiomi, Masao
    Tanaka, Masahiko
    Saito, Akira
    Fujiwara, Kenji
    Mochida, Satoshi
    INTERNAL MEDICINE, 2012, 51 (01) : 9 - 15
  • [24] Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients
    Preau, Marie
    Marcellin, Fabienne
    Spire, Bruno
    Ravaux, Isabelle
    Dellamonica, Pierre
    Blanc, Dominique
    Carrieri, Maria Patrizia
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (01) : 92 - 96
  • [25] High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients
    Berenguer, Juan
    Fernandez-Rodriguez, Amanda
    Angeles Jimenez-Sousa, Maria
    Cosin, Jaime
    Zarate, Paola
    Micheloud, Dariela
    Carlos Lopez, Juan
    Miralles, Pilar
    Catalan, Pilar
    Resino, Salvador
    CYTOKINE, 2012, 57 (01) : 25 - 29
  • [26] HCV RNA LEVELS AND HIV-INFECTION - EVIDENCE FOR A VIRAL INTERACTION IN HEMOPHILIC PATIENTS
    TELFER, PT
    BROWN, D
    DEVEREUX, H
    LEE, CA
    DUSHEIKO, GM
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (02) : 397 - 399
  • [27] HCV coinfection aggravated the decrease of platelet counts, but not mean platelet volume in chronic HIV-infected patients
    Lv, Linting
    Li, Yuantao
    Fan, Xueying
    Xie, Zhe
    Liang, Hua
    Shen, Tao
    SCIENTIFIC REPORTS, 2018, 8
  • [28] Fosamprenavir treatment in a highly active antiretroviral therapy schedule induces a HCV-RNA decrease and a Th1 network boost in HIV/HCV-coinfected patients
    Perrella, A.
    Sbreglia, C.
    D'Antonio, A.
    Atripaldi, L.
    Perrella, O.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (06) : 676 - 678
  • [29] During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy
    Kostadinova, Lenche
    Shive, Carey L.
    Judge, Chelsey
    Zebrowski, Elizabeth
    Compan, Anita
    Rife, Kelsey
    Hirsch, Amy
    Falck-Ytter, Yngve
    Schlatzer, Daniela M.
    Li, Xiaolin
    Chance, Mark R.
    Rodriguez, Benigno
    Popkin, Daniel L.
    Anthony, Donald D.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (09) : 1438 - 1448
  • [30] Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Chiodo, F
    Magliano, E
    Mondini, C
    Idéo, G
    JOURNAL OF HEPATOLOGY, 1999, 30 (01) : 8 - 13